The Cancer Research Institute (CRI) assembles a team to run the 2022 TCS New York City Marathon.
Walk, Run, or Move with us during the month of June to support the next great breakthroughs in cancer immunotherapy research.
Wine tasting and silent auction hosted by the CRI Associate Board
The Cancer Research Institute assembles a team to run and raise critical funds for highly promising cancer immunotherapy research.
Join Jane and Dick Landesman for a community-building fundraiser to benefit the Cancer Research Institute.
Team CRI runs the 2021 TCS New York City Marathon and helps raise critical funds for highly promising cancer immunotherapy research all around the world.
The CRI Answer to Cancer x Peloton Ride is the CRI Associate Board’s signature fundraising event to collectively fund a future immune to cancer.
Through the Kitchen supports CRI’s Irvington Postdoctoral Fellowship Program.
What's Your '21? Set your goal. Choose your impact in 2021.
Team CRI runs the 2020 TCS New York City Marathon and helps raise critical funds for highly promising cancer immunotherapy research all around the world.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Rare and ultra-rare cancers affect around 20,000 people in the United States alone, according to Foundation Medicine, Inc. Immunotherapy research in some of the more common cancers and the identification of biomarkers that can predict patient responses is opening this new approach to cancer treatment up to patients whose cancers currently receive little direct attention.
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.